| Market Cap | ₹1,411Cr |
| ROE | 13.86% |
| P/E Ratio(TTM) | 45.32 |
| EPS(TTM) | 5.98 |
| P/B Ratio | 6.13 |
| Dividend Yield | 0.00% |
| Industry P/E | 60.08 |
| Book Value | 44.24 |
| Debt to Equity | 0.51 |
| Face Value | 2 |
| Parent Organisation | Suraksha Diagnostic |
| NSE Symbol | SURAKSHA |
| FUND NAME | AUM(%) |
|---|---|
| Nippon India Pharma Fund Direct Growth | 1.35% |
| JM Value Fund Direct Plan Growth | 0.71% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 43.62 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 69.87 | ||
| Metropolis Healthcare | NA (0.00%) | 62.57 | ||
| Thyrocare Technologies | NA (0.00%) | 57.81 |